M

MeiraGTx Holdings plc
D

MGTX

7.27000
USD
0.00
(0.00%)
مغلق
حجم التداول
8,338
الربح لكل سهم
0
العائد الربحي
-
P/E
-3
حجم السوق
581,244,613
أصول ذات صلة
LI
LI
-0.200
(-0.79%)
25.040 USD
N
NIO
-0.05500
(-1.35%)
4.01500 USD
RIVN
RIVN
-0.020
(-0.14%)
13.820 USD
TSLA
TSLA
6.17
(2.20%)
287.24 USD
W
WKHS
0.10000
(9.62%)
1.14000 USD
XPEV
XPEV
-0.105
(-0.53%)
19.765 USD
المزيد
الأخبار المقالات

العنوان: MeiraGTx Holdings plc

القطاع: Healthcare
الصناعة: Biotechnology
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.